To evaluate the protective effects of L-carnitine on the ischemic myocardium, the effects of its administration on tissue levels of high energy phosphate and phospholipids were studied in ischemic dog hearts.
SUMMARY
To evaluate the protective effects of L-carnitine on the ischemic myocardium, the effects of its administration on tissue levels of high energy phosphate and phospholipids were studied in ischemic dog hearts.
Myocardial ischemia was induced by the ligation of the left anterior descending coronary artery for 40min.
In the experiment, L-carnitine (300mg/kg) was administered intravenously prior to coronary artery ligation. Mitochondrial phospholipids were extracted from nonischemic and ischemic regions of the myocardium and subsequently analyzed.
In ischemic myocardial tissues, levels of adenosine 5'-triphosphate (ATP) were reduced. The decrease was significantly elevated by L-carnitine pretreatment. The mitochondrial fractions obtained from ischemic myocardia had significantly lower levels of phospholipids than those obtained from nonischemic tissues.
Moreover, the amounts of phosphatidylcholine, phosphatidylinositol and phosphatidylethanolamine were significantly decreased in ischemic myocardial tissues. L-carnitinepretreatment prevented the reduction of these phospholipids. Lysophosphatidylethanolamine and sphingomyelin did not show statistically significant decreases. This may explain why the administration of carnitine has beneficial effects on ischemic myocardium.
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ATP was determined using hexokinase and glucose-6-phosphate dehydrogenase according to Lamprecht and Trautshold.6) Mitochondrial preparation: Samples were trimmed of adipose tissue and minced with scissors in a cold room. The samples were suspended in about 5vol of cold 0.25M sucrose 50mM Tris(hydroxymethyl) aminomethane (Tris), pH 7.4. The suspension was immediately homogenized for 20 sec with a Polytron tissue homogenizer (Kinematica PT10/35) with an external rheostat setting at 5.5. The homogenate was centrifuged at 1,000g for 10min. After centrifugation, the supernatant layer was recovered and passed through a cheesecloth. The supernatant was centrifuged at 12,000g for 10min. The sediment was suspended in 0.25M sucrose 10mM Tris, pH 7.7 and centrifuged at 24,000g for 10min. The resulting sediment was resuspended in 0.25M sucrose 10 mM Tris, pH 7.7. Fig.1 shows the morphology of the prepared mitochondria.
Measurement of mitochondrial phospholipid content: Mitochondrial lipids were extracted using a modified method of Folch et al.7) A mitochondrial suspension (1ml) was extracted with a 25ml solution of CHCl3:CH3OH=2:1 and filtered through filter paper. Many authors have reported various changes in phospholipid composition in the ischemic myocardium. Bruce and Myers24) found that phosphatidylserine, phosphatidylcholine and cardiolipin decreased but lysophosphatidyleholine and phosphatidylethanolamine remained unchanged. Boime et al25) found that the phosphatidylcholine content was unchanged but the phosphatidylethanolamine content was decreased. Chien et al19) reported that the phosphatidylethanolamine and phosphatidylcholine levels were decreased, but without any corresponding increase in lysophospholipid content.
We found a significant decrease in the amount of total phospholipids, phosphatidylcholine, phosphatidylinositol and phosphatidylethanolamine in the mitochondrial fractions prepared from ischemic myocardia. Thus in the ischemic myocardium, the hydrolysis of membrane phospholipids may be increased in the environment of ATP depletion and the accumulation of long chain acyl CoA and long chain acyl carnitine.
These amphiphiles can produce changes in membrane function and structure by the insertion of monomers into the membrane by a detergent effect that depletes the membrane of some of its components26) and affects its integrity.
Decreases in ATP and total phospholipid levels were prevented by the administration of L-carnitine. Furthermore, the determination of individual phospholipids showed that the decreases in phosphatidylcholine, phosphatidylinositol and phosphatidylethanolamine were also prevented by the administration of L-carnitine.
The present results suggest that L-carnitine has preventive effects on the degradation of mitochondrial membrane phospholipids in ischemic myocardium and L-carnitine is a useful drug for the treatment of ischemic heart Jpn. Heart J. M arch 1987
diseases.
